Half the Sky Pharmaceutical International Group, a well-known trademark in Jiangxi Province, focuses on gynecological Chinese patent medicine/health care products, and its compound black chicken oral liquid/milk Ning pill/Ejiao Yishou oral liquid is more famous
Founded in April 1998, Half the Sky Pharmaceutical International Group (Hong Kong) Co., Ltd. currently owns a number of subsidiaries such as Jiangxi Half the Sky Pharmaceutical Co., Ltd., Shenzhen Half the Sky Health Products Co., Ltd., Shenzhen Jinyaofang Pharmaceutical Co., Ltd., and has a production base covering an area of more than 160,000 square meters in Taihe Economic Development Zone, Jiangxi Province - Half the Sky Pharmaceutical International Group Industrial City, with fixed assets of more than RMB 200 million, and its domestic headquarters is located in Shenzhen.
In line with the business tenet of "concentrating on making good medicines, healthy half the sky", Half the Sky Pharmaceutical International Group is professionally committed to the research and development, production and sales of gynecological Chinese patent medicines and health care products, and has formed a gynecological product line with various functions such as menstrual regulation, breast, blood tonics, anti-inflammatory, detoxification, etc., the main varieties are national traditional Chinese medicine protected varieties and national new medicine compound black chicken oral liquid, Runing pills, Ejiao Yishou oral liquid, black chicken Baifeng pills, aloe vera capsules, women's Shujie lotion, women's Yankang tablets, etc.
Half the Sky Pharmaceutical International Group's member company, Jiangxi Half the Sky Pharmaceutical Co., Ltd., has a number of domestic advanced production lines such as oral liquid, syrup, honey pills, water pills, lotions, etc.; The production capacity is more than 1 billion yuan; In 2004 and 2009, it passed the GMP certification of the State Food and Drug Administration. The second phase of the project, which is currently under construction, includes tablets, capsules, granules and other dosage forms. The second phase of the project is expected to be completed in 2012.
Half the Sky Pharmaceutical International Group adheres to the market-oriented, and its subordinate member company Shenzhen Jinyaofang Pharmaceutical Co., Ltd. is the marketing center of the group company, which has successfully passed the GSP certification in June 2OO4, and has built a sales network centered on Shenzhen and radiating South China, East China, Central South and Southwest China, and has set up more than 200 marketing branches in more than 20 provinces, municipalities and autonomous regions such as Guangdong, Guangxi, Yunnan, Guizhou, Hunan, Hubei, Chongqing, Sichuan, Jiangsu, Jiangxi, Anhui, Zhejiang, Shandong, etc. A professional sales force of more than 1,000 people has been established.
Half the Sky Pharmaceutical International Group attaches great importance to scientific and technological innovation, and has established close cooperation with many well-known pharmaceutical research institutions at home and abroad, realizing a good development pattern of friendly interaction between product research and development, information exchange, market development, and talent training, and production, reserve, research and conception.
In the future, Half the Sky Pharmaceutical International Group will continue the path of "professional gynecology brand", enrich its product group, expand its sales scale, further enhance its brand influence through mergers and acquisitions, cooperation and other channels, actively seek listing, and achieve the strategic goal of becoming the first gynecological brand in China's pharmaceutical market.
